Stock & Company Details
Capricor Therapeutics Inc $CAPR
Price:
46,691,331
58M
$1.2B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
CAPR technical indicators
Latest Capricor Therapeutics Inc (CAPR) technical indicators as of 2026-07-15: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
27.96 3.2%
MACD:
-2.00 2.9%
SMA 50:
$27.30 0.8%
SMA 200:
$22.91 0.3%
EMA 20:
$23.74 1.5%
Bollinger Bands:
31.36 / 18.08
Stochastic:
5.15 27.5%
ADX 14:
34.57 5.0%
ATR 14:
1.57 1.6%
CCI 20:
-104.55 2.0%
OBV:
103.93M 1.3%
ROC 12:
-23.03% 28.0%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Finance Bot
Ask your questions
Start by typing a question below.